Seed Innovations Ltd

Investee Company Update: Yooma Wellness Inc.

RNS Number : 8067M
Seed Innovations Limited
25 May 2022
 

Seed Innovations Ltd / AIM: SEED / Sector: Closed End Investments

 

25 May 2022

 

SEED Innovations Limited ('SEED' or the 'Company')

 

Investee Company Update: Yooma Wellness Inc.

 

SEED Innovations Ltd, the AIM quoted company investing in fast growing and industry leading businesses with a focus on the medical cannabis, health and wellness space, notes that following its suspension of trading announced on 4 May 2022, investee company Yooma Wellness Inc. ('Yooma') has been reinstated for trading on the Canadian Securities Exchange ('CSE'), with immediate effect.

Yooma is a global vertically integrated wellness platform that develops and markets a portfolio of CBD and wellness brands. SEED has a holding of 4,427,609 ordinary shares in Yooma representing approximately 4.4% of Yooma's issued share capital.

 

About Yooma Wellness Inc.

Yooma's mission is to build a vertically-integrated global leader in the manufacturing, marketing, distribution, and sale of wellness products including hemp seed oil and hemp-derived and cannabinoid (CBD) ingredients. The company leverages strategically curated sales channels and ecommerce networks to deliver a diverse mix of wellness products through operating subsidiaries in the United States, United Kingdom, France and Japan. Learn more at   www.yooma.ca

 

***ENDS***

 

For further information on the Company please visit   www.seedinnovations.co  or contact:

 

 

Ed McDermott

Lance de Jersey

SEED Innovations Ltd

E: [email protected]

 

James Biddle

Roland Cornish

Beaumont   Cornish   Limited,

Nomad

T: (0)20 7628 3396

 

Isabella Pierre

Damon Heath

Shard Capital Partners LLP

Broker

T: (0)20 7186 9927

Catherine Leftley

Isabelle Morris

St Brides Partners Ltd,

Financial PR

E: [email protected]

 

 

Notes

SEED Innovations is an AIM quoted investment company focused primarily on disruptive high growth life sciences and technology businesses particularly within the medical cannabis arena. The Company's strategy is to identify early-stage opportunities that have an upcoming investment catalyst and grow its portfolio in terms of value whilst limiting the number of investee companies to a level where relevant time can be devoted to each.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFIVEVIEFIF